EG13520A - Forme cristalline du sel de sodium d'un derive oximine de l'acide 7-amino-thiazolyl acetamido cephalosporan;que,son procede de preparation et son application comme medicament - Google Patents

Forme cristalline du sel de sodium d'un derive oximine de l'acide 7-amino-thiazolyl acetamido cephalosporan;que,son procede de preparation et son application comme medicament

Info

Publication number
EG13520A
EG13520A EG510/78A EG51078A EG13520A EG 13520 A EG13520 A EG 13520A EG 510/78 A EG510/78 A EG 510/78A EG 51078 A EG51078 A EG 51078A EG 13520 A EG13520 A EG 13520A
Authority
EG
Egypt
Prior art keywords
son
cephalosporan
oximine
acide
que
Prior art date
Application number
EG510/78A
Other languages
English (en)
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9194564&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EG13520(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Application granted granted Critical
Publication of EG13520A publication Critical patent/EG13520A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EG510/78A 1977-08-17 1978-08-16 Forme cristalline du sel de sodium d'un derive oximine de l'acide 7-amino-thiazolyl acetamido cephalosporan;que,son procede de preparation et son application comme medicament EG13520A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7725142A FR2400519A1 (fr) 1977-08-17 1977-08-17 Forme cristalline du sel de sodium d'un derive oximine de l'acide 7-amino-thiazolyl acetamido cephalosporanique, son procede de preparation et son application comme medicament

Publications (1)

Publication Number Publication Date
EG13520A true EG13520A (en) 1982-03-31

Family

ID=9194564

Family Applications (1)

Application Number Title Priority Date Filing Date
EG510/78A EG13520A (en) 1977-08-17 1978-08-16 Forme cristalline du sel de sodium d'un derive oximine de l'acide 7-amino-thiazolyl acetamido cephalosporan;que,son procede de preparation et son application comme medicament

Country Status (34)

Country Link
US (1) US4224371A (es)
EP (1) EP0001024B1 (es)
JP (1) JPS5441890A (es)
AT (2) AT366049B (es)
AU (1) AU520898B2 (es)
BG (2) BG33887A3 (es)
CA (1) CA1121343A (es)
CS (2) CS207646B2 (es)
DD (1) DD137588A5 (es)
DE (1) DE2860358D1 (es)
DK (2) DK152213C (es)
EG (1) EG13520A (es)
ES (1) ES472381A1 (es)
FI (1) FI65433C (es)
FR (1) FR2400519A1 (es)
GE (2) GEP19960476B (es)
GR (1) GR73661B (es)
HR (1) HRP931395B1 (es)
HU (1) HU181497B (es)
IE (1) IE47230B1 (es)
IL (1) IL55186A (es)
IT (1) IT1107961B (es)
MD (2) MD247C2 (es)
MX (2) MX5448E (es)
NO (1) NO156168C (es)
NZ (1) NZ188163A (es)
OA (1) OA06016A (es)
PL (1) PL126619B1 (es)
PT (1) PT68431A (es)
RO (1) RO79999A (es)
SI (1) SI7811917A8 (es)
SU (2) SU799666A3 (es)
YU (1) YU42166B (es)
ZA (1) ZA784187B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60120886A (ja) * 1983-12-02 1985-06-28 Takeda Chem Ind Ltd セフェムカルボン酸のナトリウム塩の結晶
JPS60142987A (ja) * 1983-12-29 1985-07-29 Mochida Pharmaceut Co Ltd セフアロスポリン誘導体
DE150507T1 (de) * 1983-12-29 1987-02-26 Mochida Pharmaceutical Co., Ltd., Tokio/Tokyo Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutishe praeparate.
US4840945A (en) * 1985-04-01 1989-06-20 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
US4937330A (en) * 1985-08-12 1990-06-26 The Upjohn Company Conversion of cephalosporin hydrohalide salt to alkali metal salt
US4880798A (en) * 1986-11-25 1989-11-14 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
JPS63132893A (ja) * 1986-11-25 1988-06-04 Mochida Pharmaceut Co Ltd 新規セフアロスポリン誘導体、その製法およびそれらを有効成分とする抗菌剤
RU2021274C1 (ru) 1991-05-17 1994-10-15 Польска Акадэмия Наук Институт Хэмии Органичнэй Способ получения аминотиазолильных производных цефалоспорина
US5318781A (en) * 1993-04-06 1994-06-07 Hoffmann-La Roche Inc. Absorption enhancement of antibiotics
US5574154A (en) * 1994-09-29 1996-11-12 Alnejma Bulk Pharmaceutical Co. A.B.P.C. Process for the preparation of cephalosporanic compounds
GB9423459D0 (en) * 1994-11-21 1995-01-11 Biochemie Gmbh Silylation process
AT402928B (de) * 1994-12-23 1997-09-25 Biochemie Gmbh Neues verfahren zur herstellung von cefotaxim
AU690482B2 (en) * 1996-03-18 1998-04-23 Ranbaxy Laboratories Limited Process for producing cephalosporin antibiotics
GB9717629D0 (en) * 1997-08-21 1997-10-22 Johnson Matthey Plc Removal of residual organic solvents
WO2001092254A1 (fr) * 2000-05-30 2001-12-06 Fujisawa Pharmaceutical Co., Ltd. Procede permettant de remplacer des solvants contenus dans des cristaux de type clathrates
WO2004063203A1 (en) * 2003-01-10 2004-07-29 Orchid Chemicals & Pharmaceuticals Ltd Process for the preparation of cefotaxime sodium
CN100361995C (zh) * 2004-10-27 2008-01-16 山东瑞阳制药有限公司 注射级无菌头孢噻肟钠的一步法制备工艺

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3970651A (en) * 1974-01-07 1976-07-20 Bristol-Myers Company Crystalline cephalosporin derivative
US3985747A (en) * 1974-05-24 1976-10-12 Bristol-Myers Company Crystalline sesquihydrate of 7-[D-α-amino-α-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
US4006138A (en) * 1975-04-11 1977-02-01 Eli Lilly And Company Crystalline form of sodium O-formylcefamandole
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
SE440655B (sv) * 1976-01-23 1985-08-12 Roussel Uclaf Sett att framstella nya oximderivat av 7-amino-tiazolyl-acetamido-cefalosporansyra

Also Published As

Publication number Publication date
JPS5441890A (en) 1979-04-03
US4224371A (en) 1980-09-23
PL126619B1 (en) 1983-08-31
NO156168B (no) 1987-04-27
HRP931395B1 (en) 1996-04-30
DD137588A5 (de) 1979-09-12
EP0001024B1 (fr) 1981-01-21
FI65433C (fi) 1984-05-10
GEP19960475B (en) 1996-07-22
IT7850648A0 (it) 1978-08-08
DE2860358D1 (en) 1981-03-12
DK163514C (da) 1992-07-27
SI7811917A8 (en) 1997-12-31
IE781669L (en) 1979-02-17
NO782782L (no) 1979-02-20
DK159786A (da) 1986-04-09
MD225C2 (ro) 1995-12-31
DK152213B (da) 1988-02-08
MD247B1 (ro) 1995-07-31
EP0001024A1 (fr) 1979-03-07
PT68431A (fr) 1978-09-01
NZ188163A (en) 1981-10-19
ZA784187B (en) 1979-09-26
ATA52280A (de) 1981-07-15
CS207647B2 (en) 1981-08-31
FI782494A (fi) 1979-02-18
AU3896578A (en) 1980-02-21
BG33888A3 (en) 1983-05-16
CS207646B2 (en) 1981-08-31
JPS6145626B2 (es) 1986-10-08
ATA563578A (de) 1981-07-15
MX5448E (es) 1983-08-09
PL209080A1 (pl) 1979-06-04
SU852175A3 (ru) 1981-07-30
YU191778A (en) 1983-02-28
YU42166B (en) 1988-06-30
IT1107961B (it) 1985-12-02
DK152213C (da) 1988-07-11
DK361078A (da) 1979-02-18
NO156168C (no) 1987-08-19
AU520898B2 (en) 1982-03-04
CA1121343A (fr) 1982-04-06
AT366050B (de) 1982-03-10
FR2400519A1 (fr) 1979-03-16
GEP19960476B (en) 1996-07-22
MD225B1 (ro) 1995-06-30
DK163514B (da) 1992-03-09
ES472381A1 (es) 1979-03-16
BG33887A3 (en) 1983-05-16
MD247C2 (ro) 1995-12-31
DK159786D0 (da) 1986-04-09
MX155976A (es) 1988-06-06
FR2400519B1 (es) 1980-05-16
HU181497B (en) 1983-07-28
IE47230B1 (en) 1984-01-25
AT366049B (de) 1982-03-10
IL55186A0 (en) 1978-09-29
GR73661B (es) 1984-03-28
FI65433B (fi) 1984-01-31
IL55186A (en) 1981-07-31
RO79999A (ro) 1982-10-11
OA06016A (fr) 1981-06-30
SU799666A3 (ru) 1981-01-23

Similar Documents

Publication Publication Date Title
EG13520A (en) Forme cristalline du sel de sodium d'un derive oximine de l'acide 7-amino-thiazolyl acetamido cephalosporan;que,son procede de preparation et son application comme medicament
DE3062467D1 (en) Process for the preparation of 4,1',6'-trichloro-4,1',6'-trideoxy-galactosucrose
BE865260A (fr) Procede de preparation d'octafluoropropane
DE2860060D1 (en) Process for the preparation of 2,2'-dichlorohydrazobenzene
IL53587A0 (en) Process for the preparation of 2,5-dichloro-phenol
PT68303A (en) Process for the preparation of dibenzo/b,f/thiepin
PT67847A (en) Process for the preparation of interphenylene 8-aza-9-dioxothia-11,12-secoprostaglandins
GB2000137B (en) Process for the preparation of 7,8-dihydro-14-hydroxynormorphine
GR64236B (en) Method for the preparation of new substituted in position-ii,5,ii-dihydro-6h-pyrido(2,3-6)(1,4)benzodiazepin-6-ones
YU40186B (en) Process for preparing new (2,3-dihydro-2,2-dimethylbenzofurane-7-yloxy-n-methylcarbomamoyl)-n'-alkylcarbomyl)-sulfides
LU80567A1 (fr) Procede pour la preparation de 3-iodo-et de 3 bromorifamycine s
LU80272A1 (fr) Procede de preparation d'agents therapeutiques antiallergiques
DE2860031D1 (en) Process for the preparation of 3,4-methylendioxymandelic acid
BE880509A (fr) Procede de preparation de 2',6'-dialkyl-n-alcoxymethyl-2-chloro-acetanilides
BE865728A (fr) Procede de preparation du 2,3-dimethylpentanal
PH17661A (en) Process for preparation of 9(2,6-dihalobenzyl)adedines
YU39517B (en) Process for obtaining 4''-amino epimeric oleandomycin
EG17409A (en) Moule de coulee sous basse pression
ZA774753B (en) Process for the manufacture of 2,9-dioxatricyclo(4,3,1,3 3'7)decanen
PT67605B (en) Process for the preparation of 2,9-dioxatricyclo <4,3,1,03,7>-decanes
PT68626A (en) Process for the preparation of 2-furyl-(3,4-dimethyl-2-pyridyl)-carbinol
BE867459A (fr) Procede de preparation d'alcane-polyols
LU80602A1 (fr) Procede de preparation de l'acide d,1-beta-benzoylamino-isobutyrique
LU80336A1 (fr) Procede de preparation d'ureidonitriles utiles comme antihypertenseurs
BE863860A (fr) Procede de preparation de l'alpha-naphtol